TLDR Oracle posts fiscal Q2 2026 results December 10, Wall Street forecasts $1.64 EPS on $16.19 billion revenue Shares dropped 7.4% over past month despite 33% year-to-date climb on debt worries Company’s debt ballooned to $111.6 billion from $84.5 billion year-over-year to fund AI expansion $18 billion September bond offering ranks among tech’s largest debt [...] The post Oracle (ORCL) Stock: Can Wednesday’s Earnings Reverse the 36% Drop? appeared first on Blockonomi.TLDR Oracle posts fiscal Q2 2026 results December 10, Wall Street forecasts $1.64 EPS on $16.19 billion revenue Shares dropped 7.4% over past month despite 33% year-to-date climb on debt worries Company’s debt ballooned to $111.6 billion from $84.5 billion year-over-year to fund AI expansion $18 billion September bond offering ranks among tech’s largest debt [...] The post Oracle (ORCL) Stock: Can Wednesday’s Earnings Reverse the 36% Drop? appeared first on Blockonomi.

Oracle (ORCL) Stock: Can Wednesday’s Earnings Reverse the 36% Drop?

TLDR

  • Oracle posts fiscal Q2 2026 results December 10, Wall Street forecasts $1.64 EPS on $16.19 billion revenue
  • Shares dropped 7.4% over past month despite 33% year-to-date climb on debt worries
  • Company’s debt ballooned to $111.6 billion from $84.5 billion year-over-year to fund AI expansion
  • $18 billion September bond offering ranks among tech’s largest debt issuances ever
  • $300 billion OpenAI partnership and 359% surge in contracted revenue backlog fuel mixed sentiment

Oracle delivers fiscal second-quarter earnings after Wednesday’s market close. Analysts project adjusted earnings of $1.64 per share and revenue of $16.19 billion, showing 11.6% and 15% year-over-year growth.


ORCL Stock Card
Oracle Corporation, ORCL

The stock endured a turbulent October, plunging 23% in its worst monthly performance since 2001. Concerns about debt obligations tied to AI infrastructure spending drove the selloff.

Oracle’s September bond sale raised $18 billion in one of tech’s largest debt offerings. The company now stands as the top investment grade debt issuer among non-financial firms, per Citi. Total debt reached $111.6 billion as of August, up from $84.5 billion a year prior.

Cash and equivalents slipped to $10.45 billion from $10.6 billion during the same timeframe. Citi analyst Tyler Radke estimates Oracle will raise $20 billion to $30 billion in debt annually over the next three years to fund data center construction.

OpenAI Deal Reshapes Oracle’s Position

A $300 billion agreement with OpenAI surfaced in September. The deal involves computing power purchases spanning roughly five years beginning in 2027. This partnership elevated Oracle’s standing in the AI infrastructure race.

TD Cowen analyst Derrick Wood rates the stock a Buy with a $400 target. He notes shares trade at 22x calendar year 2027 earnings, which he views as trough valuations. Wood believes confirmation of Oracle Cloud Infrastructure growth through fiscal 2026 could ease capacity concerns.

RBC Capital analyst Rishi Jaluria maintains a Hold rating with a $310 price target. He suggests Oracle might explore off-balance sheet facilities, equity raises, or sovereign wealth fund investments. The analyst references Meta’s $27 billion Blue Owl Capital joint venture as a potential financing template.

Credit default swaps for Oracle’s 5-year debt hit multi-year highs. Barclays and Morgan Stanley analysts recommend clients purchase these instruments as protection. Morgan Stanley noted the swaps attracted inexperienced “tourists” alongside typical credit investors.

Revenue Backlog Offers Counterbalance

Remaining performance obligations could exceed $500 billion, representing a more than fivefold increase year-over-year. These contracted revenues await recognition on financial statements. Oracle’s September disclosure of 359% RPO growth to $455 billion sparked a 36% single-day stock surge, the best since 1992.

Shares have since erased those gains entirely. D.A. Davidson analyst Gil Luria plans to monitor Oracle’s core database business closely. This higher-margin segment determines the company’s flexibility for additional capital raises.

Daniel Sorid, Citi’s head of U.S. investment grade credit strategy, expressed unease about the capital-intensive transformation. He highlighted the enormous funding requirements during an investor video call.

Oracle secured construction loans from a banking consortium for data centers in New Mexico and Wisconsin. New CEOs Clay Magouyrk and Mike Sicilia face pressure demonstrating AI demand justifies aggressive buildout plans.

Investors await confirmation that AI demand supports Oracle’s spending strategy. Wednesday’s fiscal second-quarter results will either validate the infrastructure investment thesis or deepen financial concerns about the company’s leveraged position heading into 2026.

The post Oracle (ORCL) Stock: Can Wednesday’s Earnings Reverse the 36% Drop? appeared first on Blockonomi.

Market Opportunity
4 Logo
4 Price(4)
$0.02207
$0.02207$0.02207
+0.09%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
XRP Yield Strategies vs. Traditional Staking: Which Offers the Highest Returns for Long-Term Holders?

XRP Yield Strategies vs. Traditional Staking: Which Offers the Highest Returns for Long-Term Holders?

[January 20, 2026] — As the cryptocurrency market matures, investors are no longer content with simply holding (HODL) but are beginning to seek the “productivity
Share
Coincentral2026/01/20 23:25
Value Gene Report: Humanoid Robots to Reshape Food Manufacturing Within Six Years as Labor Crisis Deepens

Value Gene Report: Humanoid Robots to Reshape Food Manufacturing Within Six Years as Labor Crisis Deepens

DALLAS, Jan. 20, 2026 /PRNewswire/ — Value Gene Consulting Group today released a new report, “How Humanoids Will Reshape Food Manufacturing,” stating that humanoids
Share
AI Journal2026/01/20 23:15